Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus

Abstract

The presence of serum DNRAbs can account for some aspects of brain dysfunction in patients with SLE, and the addition of regional measurements of resting brain metabolism improves the assessment and precise attribution of central nervous system manifestations related to SLE.